Sources

4 Total Sources

STEM-PD Shows 12-Month Safety in 8-Patient Parkinson's Trial as PET Signals Graft Survival

BIOENGINEER.ORG1d ago

STEM-PD Trial Presents Promising Parkinson's Stem Cell Therapy Data at ISSCR 2026

The Science of Parkinson's (@ScienceofPD) / Posts / X

Nature.com2d ago

STEM-PD Phase 1/2 Trial Reports 12-Month Safety, Interim Efficacy for Parkinson's Disease

link.springer.com2d ago

Safety and preliminary efficacy of autologous bone marrow-derived mesenchymal stem cell transplantation in hereditary cerebellar ataxia: phase I/IIa clinical trial | Stem Cell Research & Therapy | Springer Nature Link